Download PDF
Thromb Haemost 1981; 46(02): 571
DOI: 10.1055/s-0038-1653417
Letters to the Editor
Schattauer GmbH Stuttgart

Normal Prostacyclin-Like Activity in Thrombotic Thrombocytopenic Purpura

M Pini
5 a Divisione Medica e Centro Emostasi Ospedali Riuniti di Parma, Parma, Italy
,
C Manotti
5 a Divisione Medica e Centro Emostasi Ospedali Riuniti di Parma, Parma, Italy
,
R Quintavalla
5 a Divisione Medica e Centro Emostasi Ospedali Riuniti di Parma, Parma, Italy
,
A G Dettori
5 a Divisione Medica e Centro Emostasi Ospedali Riuniti di Parma, Parma, Italy
› Author Affiliations
Further Information

Publication History

Received 26 May 1981

Accepted 24 June 1981

Publication Date:
05 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Kwaan HC. The pathogenesis of thrombotic thrombocytopenic purpura. Sem Thromb Haemostas 1979; 5: 184-198
    PubMedGoogle Scholar
  • 2 Weisenburger DD, Fry GL, Hoak JC. Thrombotic thrombocytopenic purpura: conflicting results of in-vitro studies. Lancet 1980; 1: 99-100
    PubMedGoogle Scholar
  • 3 Hensby CN, Lewis PJ, Hilgord P, Mufti GJ, Hows J, Webster J. Prostacyclin deficiency in thrombotic thrombocytopenic purpura. Lancet 1979; 2: 748
    PubMedGoogle Scholar
  • 4 Machin SJ, Defreyn G, Chamone DA F, Carreras L, Vermylen J. Serial 6-Keto PGE1α levels in thrombotic thrombocytopenic purpura. Sixth International Congress on Thrombosis of the Mediterranean League against Thromboembolic Diseases. Monte Carlo: 10/1980: 23-25 (Abstract)
    Google Scholar
  • 5 Remuzzi G, Misiani R, Mecca G, DeGaetano G, Donati MB. Thrombotic thrombocytopenic purpura - A deficiency of plasma factors regulating platelet-vessel wall interaction?. N Engl J Med 1978; 299: 311
    PubMedGoogle Scholar
  • 6 Moncada S, Higgs EA, Vane TR. Human arterial and venous tissues generate prostacyclin (Prostaglandin X), a potent inhibitor of platelet aggregation. Lancet 1977; 1: 18-20
    PubMedGoogle Scholar
  • 7 Budd GT, Bukowski RM, Lucas FV, Cato AE, Cocchetto DM. Prostacyclin therapy of thrombotic thrombocytopenic purpura. Lancet 1980; 2: 915
    PubMedGoogle Scholar